NORTH READING, Mass., May 6, 2019 /PRNewswire/ — TraceLink Inc., the world’s largest integrated digital supply network, providing real-time information sharing for better patient outcomes, today announced financial and company results for the first quarter of 2019.
Financial growth highlights for Q1 2019 include:
“We continue to see significant growth in both new and existing customers that are investing deeper into our digital supply network solutions. Last quarter alone, there were over 1 billion serial numbers commissioned with a rapid acceleration of CMO connections, and we expect this momentum to continue as our network and solution portfolio expands,” said Shabbir Dahod, president and CEO, TraceLink. “TraceLink’s network continues to be a differentiator and as we look forward, we are committed to continuing to advance the industry by utilizing our knowledge and expertise to create a dynamic, information sharing ecosystem that will not only transform business processes and deliver value to the pharmaceutical supply chain, but ultimately yield better patient outcomes.”
Additional Q1 2019 growth highlights and milestones include:
Additional Resources:
Follow TraceLink:
About TraceLink
TraceLink is the world’s largest integrated digital supply network, providing real-time information sharing for better patient outcomes. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. The TraceLink digital supply network is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com.
TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
View original content to download multimedia:http://www.prnewswire.com/news-releases/tracelink-achieves-44-overall-revenue-growth-for-q1-2019-300844198.html
SOURCE TraceLink
PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…
NEW YORK, Nov. 22, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape -…
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…
3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…
The new app allows users to browse services, book IV therapy, manage appointments, purchase packages,…
PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform…